Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Portage Biotech Inc.

Latest From Portage Biotech Inc.

Finance Watch: J.P. Morgan Conference To Offer Glimpse Of 2024 Funding Forecast

Public Company Edition: Discussions at the J.P. Morgan Healthcare Conference 8-11 January in San Francisco should offer some insight on industry’s and investors’ expectations about the financial markets in 2024. The year started with some big financings, but also some new job cuts.

Financing Restructuring

Scrip Asks...What Does 2023 Hold For Biopharma? Part 2: M&A And Partnering

Deal-making between big pharma and biotech looks set to rise with a looming patent cliff increasing the need for the former to replenish its pipelines. Meanwhile, biotechs need partners to help them advance amid the ongoing big freeze on raising cash on public markets.

Scrip Asks M & A

Scrip Asks...What Does 2023 Hold For Biopharma? Part 1: The Funding Environment

With valuations down and borrowing costs up, many industry insiders are expecting Darwinian scenes in biotech this year. Survival of the fittest is the order of the day: companies with riskier, less commercially defined propositions will struggle, while platform companies with multiple shots on strong goals will increasingly find favor in a more risk-averse environment.

Scrip Asks Financing

Portage Buys Tarus, Gaining Cancer Assets Targeting Immune Evasion

Acquisition valued at roughly $21m upfront for two clinical and two preclinical adenosine receptor antagonists.

Deals M & A
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
  • Biotechnology
    • Drug Discovery Technologies
    • Large Molecule
    • Drug Discovery Technologies
      • Genomics-Proteomics
  • Other Names / Subsidiaries
    • 3Legs Resources plc
    • Biohaven Pharmaceutical Holding Company Ltd.
    • Bontan Corporation, Inc.
    • Intensity Holdings Limited
    • Intensity Therapeutics, Inc.
    • iOx Therapeutics, Ltd
    • Oncomer
    • Portage Acquisition Inc.
    • Portage Pharmaceuticals Limited (PPL)
    • JV Co
    • Portage Glasgow Limited (PGL)
    • Nekonal SARL
    • SalvaRx Limited
    • Saugatuck Therapeutics Ltd.
    • Rift Biotherapeutics
    • SalvaRx Group plc
    • Tarus Therapeutics